Mondrian Investment Partners LTD

13F Filings History

Latest 13F report
Q3 2024 - Nov 5, 2024
Value $
$6.2B
Signature - Title
Ed Lambert - CCO
Location
London, United Kingdom
Summary
This page shows a list of all the recent 13F filings made by Mondrian Investment Partners LTD. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Mondrian Investment Partners LTD reported 102 stock holdings with total value $6.2B as of Q3 2024. Top holdings included PHG, LYG, SAN, SONY, and GSK.
Holdings Value

List of Other Managers Reporting for Mondrian Investment Partners LTD:

Name Holdings Value Location File Number
Russell Investments Group, Ltd. $69B London, United Kingdom 028-17598
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 102 $6.2B +$159M -$408M -$249M PHG, LYG, SAN, SONY, GSK 13F-HR 11/5/2024, 11:55 AM
Q2 2024 98 $6.1B +$541M -$1.41B -$866M PHG, LYG, SAN, SONY, GSK 13F-HR 8/12/2024, 07:46 AM
Q1 2024 100 $6.79B +$1.21B -$367M +$847M SAN, TSM, GSK, LYG, BP 13F-HR 5/7/2024, 09:59 AM
Q4 2023 100 $5.54B +$1.45B -$395M +$1.05B BAP, SAN, SONY, MSFT, DLTR 13F-HR 2/13/2024, 09:00 AM
Q3 2023 91 $4.18B +$260M -$714M -$454M BAP, PBR, ATHM, ABBV, MSFT 13F-HR 11/6/2023, 09:20 AM
Q2 2023 88 $5B +$509M -$329M +$180M TRP, BAP, MSFT, META, PBR Restatement 9/20/2023, 12:45 PM
Q1 2023 90 $4.53B +$178M -$343M -$164M BAP, MSFT, ATHM, TRP, META Restatement 9/20/2023, 02:00 PM
Q4 2022 93 $4.3B +$350M -$371M -$21.5M BAP, ATHM, BIDU, GOLD, VALE 13F-HR 2/3/2023, 09:58 AM
Q3 2022 84 $3.88B +$465M -$363M +$102M BAP, BIDU, ATHM, WMT, MSFT 13F-HR 10/21/2022, 12:48 PM
Q2 2022 80 $4.16B +$425M -$230M +$196M ATHM, BIDU, BAP, ABBV, MSFT 13F-HR 8/9/2022, 12:26 PM
Q1 2022 125 $4.43B +$397M -$1.06B -$659M BIDU, BAP, ATHM, MSFT, PGR 13F-HR 5/5/2022, 11:13 AM
Q4 2021 130 $4.98B +$504M -$600M -$95.1M BIDU, BAP, MSFT, CNC, TSM 13F-HR 2/9/2022, 09:03 AM
Q3 2021 123 $4.82B +$408M -$442M -$33.6M BIDU, BAP, TSM, ATHM, MSFT 13F-HR 10/27/2021, 11:38 AM
Q2 2021 123 $5.1B +$751M -$213M +$539M BIDU, TSM, ATHM, BAP, INFY 13F-HR 7/30/2021, 07:17 AM
Q1 2021 120 $4.49B +$1.03B -$715M +$312M BIDU, TSM, ATHM, INFY, WFC 13F-HR 5/10/2021, 09:53 AM
Q4 2020 110 $3.93B +$644M -$117M +$527M BIDU, TSM, INFY, BAP, JNJ 13F-HR 2/11/2021, 07:16 AM
Q3 2020 105 $2.77B +$362M -$243M +$118M BIDU, INFY, TSM, YUMC, GOLD 13F-HR 11/13/2020, 11:33 AM
Q2 2020 116 $2.68B +$501M -$999M -$497M TSM, BIDU, INFY, NTES, YUMC 13F-HR 8/10/2020, 10:46 AM
Q1 2020 112 $2.74B +$247M -$279M -$31.9M BABA, NTES, TSM, INFY, JNJ 13F-HR 5/12/2020, 12:47 PM
Q4 2019 125 $3.63B +$538M -$113M +$425M BABA, ERJ, NTES, TSM, INFY 13F-HR 2/6/2020, 10:50 AM
Q3 2019 125 $2.91B +$336M -$357M -$21M BABA, ERJ, TSM, INFY, ITUB 13F-HR 11/4/2019, 10:10 AM
Q2 2019 124 $2.96B +$210M -$254M -$43.1M ERJ, BABA, ITUB, TSM, JNJ 13F-HR 8/7/2019, 11:45 AM
Q1 2019 127 $3.01B +$392M -$107M +$285M ERJ, BABA, TSM, ITUB, BAP 13F-HR 4/17/2019, 02:17 PM
Q4 2018 128 $2.52B +$208M -$356M -$148M ERJ, TSM, ITUB, BAP, JNJ 13F-HR 1/24/2019, 07:08 AM
Q3 2018 122 $2.92B +$187M -$338M -$151M ERJ, TSM, ITUB, BAP, MSFT 13F-HR 11/1/2018, 01:29 PM
Q2 2018 125 $3.05B +$124M -$253M -$129M ERJ, TSM, ITUB, BAP, MSFT 13F-HR 7/25/2018, 06:44 AM
Q1 2018 130 $3.33B +$156M -$549M -$394M ERJ, ITUB, TSM, BAP, PHI 13F-HR 5/11/2018, 06:51 AM
Q4 2017 138 $3.68B +$523M -$403M +$119M ERJ, ITUB, TSM, BAP, PHI 13F-HR 1/18/2018, 10:25 AM
Q3 2017 134 $3.5B +$667M -$396M +$271M TSM, ERJ, ITUB, BAP, ABEV 13F-HR 11/2/2017, 07:17 AM
Q2 2017 136 $3.07B +$251M -$441M -$190M TSM, BAP, PHI, ABEV, BSMX 13F-HR 8/2/2017, 10:48 AM
Q1 2017 138 $3.16B +$462M -$611M -$149M TSM, PHI, BAP, ABEV, BSMX 13F-HR 4/26/2017, 10:30 AM
Q4 2016 136 $3.1B +$108M -$462M -$354M BAP, ABT, PHI, TSM, ABEV 13F-HR 2/3/2017, 09:21 AM
Q3 2016 135 $3.54B +$506M -$795M -$288M BAP, ABT, PHI, TSM, ABEV 13F-HR 11/8/2016, 11:03 AM
Q2 2016 136 $3.71B +$237M -$660M -$422M BAP, ABT, PHI, BSMX, TSM 13F-HR 8/1/2016, 12:00 PM
Q1 2016 139 $4.03B +$575M -$894M -$319M YUM, BAP, ABT, PHI, BSMX 13F-HR 5/4/2016, 10:02 AM
Q4 2015 143 $4.33B +$199M -$528M -$329M MR, YUM, PHI, CAE, BAP 13F-HR 1/13/2016, 10:05 AM
Q3 2015 142 $4.31B +$295M -$773M -$478M YUM, TEVA, PHI, MR, BAP 13F-HR 10/20/2015, 09:55 AM
Q2 2015 97 $5.49B +$224M -$436M -$212M TEVA, YUM, PHI, MR, BAP 13F-HR 7/27/2015, 11:22 AM
Q1 2015 89 $5.78B +$239M -$292M -$53.3M TEVA, YUM, PHI, MR, ENIAY Restatement 8/10/2015, 10:11 AM
Q4 2014 90 $6.21B +$409M -$576M -$167M TEVA, YUM, PHI, BAP, MR 13F-HR 1/27/2015, 12:42 PM
Q3 2014 88 $6.57B +$151M -$550M -$398M TEVA, YUM, PHI, BAP, MR 13F-HR 10/22/2014, 09:49 AM
Q2 2014 90 $7.12B +$446M -$363M +$82.6M TEVA, YUM, PHI, BAP, VALEP 13F-HR 8/4/2014, 10:33 AM
Q1 2014 90 $6.8B +$223M -$833M -$610M TEVA, YUM, VALEP, MR, PHI 13F-HR 4/15/2014, 07:25 AM
Q4 2013 88 $7.14B $0 $0 TEVA, YUM, MR, VALEP, BSMX 13F-HR 1/7/2014, 07:43 AM